Abstract
Soluble sulfotransferases (SULTs) transfer the sulfo group from the cofactor 5’-phosphoadenosine-3’-phosphosulfate (PAPS) to nucleophilic sites of relatively small acceptor molecules including various hormones and numerous xenobiotics. Sulfo conjugation of xenobiotics can lead to the formation of polar, excretable products as well as reactive, potentially mutagenic and carcinogenic metabolites. Ten SULT genes encoding 11 proteins have been identified in the human. They differ in substrate specificity and tissue distribution. Genetic polymorphisms have been detected in all human SULT genes. The functional significance of any polymorphisms that do not affect the amino acid sequence has not yet been studied. Non-synonymous single-nucleotide exchanges have been observed in SULT1A1, 1A2, 1B1, 1C1, 1C2 and 2A1. Functional consequences have primarily been explored using cDNA-expressed alloenzymes. Furthermore, an Arg213His polymorphism in SULT1A1 has a strong influence on the level of enzyme protein and activity in platelets, which have been widely used for phenotyping. Compared to other xenobiotic-metabolizing enzymes, only few studies have been conducted on associations of SULT genotypes with diseases and other health-related parameters. Statistically significant associations were observed between the SULT1A1 genotype (Arg213His) and age, obesity and certain neoplasias (mammary, pulmonary, esophageal and urothelial cancer). However, these findings require corroboration and specification. The association with neoplasias appears to be complex and varies between subgroups. This is not surprising, as SULTs are involved in the activation of some carcinogens, in the inactivation of other carcinogens, and the regulation of many hormones. It is important to study these functions of SULTs in more detail and to take into account the corresponding environmental and endogenous exposures in epidemiological studies.
Similar content being viewed by others
References
Aksoy IA, Sochorová V, Weinshilboum RM (1993) Human liver dehydroepiandrosterone sulfotransferase: nature and extent of individual variation. Clin Pharmacol Ther 54:498–506
Bamber DE, Fryer AA, Strange RC, Elder JB, Deakin M, Rajagopal R, Fawole A, Gilissen RA, Campbell FC, Coughtrie MWH (2001) Phenol sulphotransferase SULT1A1*1 genotype is associated with reduced risk of colorectal cancer. Pharmacogenetics 11:679–685
Borthwick EB, Burchell A, Coughtrie MWH (1995) Differential expression of hepatic oestrogen, phenol and dehydroepiandrosterone sulphotransferases in genetically obese diabetic (ob/ob) male and female mice. J Endocrinol 144:31–37
Bowlby MR (1993) Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons. Mol Pharmacol 43:813–819
Brix LA, Nicoll R, Zhu XY, McManus ME (1998) Structural and functional characterisation of human sulfotransferases. Chem Biol Interact 109:123–127
Brix LA, Barnett AC, Duggleby RG, Leggett B, McManus ME (1999) Analysis of the substrate specificity of human sulfotransferases SULT1A1 and SULT1A3: site-directed mutagenesis and kinetic studies. Biochemistry 38:10474–10479
Carlini EJ, Raftogianis RB, Wood TC, Jin F, Zheng W, Rebbeck TR, Weinshilboum RM (2001) Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects. Pharmacogenetics 11:57–68
Comer KA, Falany JL, Falany CN (1993) Cloning and expression of human liver dehydroepiandrosterone sulphotransferase. Biochem J 289:233–240
Coughtrie MWH (2002) Sulfation through the looking glass-recent advances in sulfotransferase research for the curious. Pharmacogenomics J 2:297–308
Coughtrie MWH, Gilissen RAHJ, Shek B, Strange RC, Fryer AA, Jones PW, Bamber DE (1999) Phenol sulphotransferase SULT1A1 polymorphism: molecular diagnosis and allele frequencies in Caucasian and African populations. Biochem J 337:45–49
Critchley JAJH, Nimmo GR, Gregson CA, Woolhouse NM, Prescott LF (1986) Inter-subject and ethnic differences in paracetamol metabolism. Br J Clin Pharmacol 22:649–657
Dajani R, Cleasby A, Neu M, Wonacott AJ, Jhoti H, Hood AM, Modi S, Hersey A, Taskinen J, Cooke RM, Manchee GR, Coughtrie MWH (1999) X-ray crystal structure of human dopamine sulfotransferase, SULT1A3: molecular modeling and quantitative structure-activity relationship analysis demonstrate a molecular basis for sulfotransferase substrate specificity. J Biol Chem 274:37862–37868
Dooley TP, Huang ZM (1996) Genomic organization and DNA sequences of two human phenol sulfotransferase genes (STP1 and STP2) on the short arm of chromosome 16. Biochem Biophys Res Commun 228:134–140
Dooley TP, Mitchison HM, Munroe PB, Probst P, Neal M, Siciliano MJ, Deng Z, Doggett NA, Callen DF, Gardiner RM, Mole SE (1994) Mapping of two phenol sulphotransferase genes, STP and STM, to 16p: candidate genes for Batten disease. Biochem Biophys Res Commun 205:482–489
Dooley TP, Haldeman-Cahill R, Joiner J, Wilborn TW (2000) Expression profiling of human sulfotransferase and sulfatase gene superfamilies in epithelial tissues and cultured cells. Biochem Biophys Res Commun 277:236–245
Eisenhofer G, Coughtrie MWH, Goldstein DS (1999) Dopamine sulphate: an enigma resolved. Clin Exp Pharmacol Physiol 26:S41–S53
Engelke CE, Meinl W, Boeing H, Glatt HR (2000) Association between functional genetic polymorphisms of human sulfotransferases 1A1 and 1A2. Pharmacogenetics 10:163–169
Engst W, Pabel U, Glatt HR (2002) Conjugation of 4-nitrophenol and 4-hydroxylonazolac in V79-derived cells expressing individual forms of human sulphotransferases. Environ Toxicol Appl Pharmacol 11:243–250
Esteban A, Calvo R, Perez-Mateo M (1996) Paracetamol metabolism in two ethnically different Spanish populations. Eur J Drug Metab Pharmacokinet 21:233–239
Falany CN (1997) Sulfation and sulfotransferases. 3. Enzymology of human cytosolic sulfotransferases. FASEB J 11:206–216
Falany JL, Falany CN (1996a) Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines. Cancer Res 56:1551–1555
Falany JL, Falany CN (1996b) Regulation of estrogen sulfotransferase in human endometrial adenocarcinoma cells by progesterone. Endocrinology 137:1395–1401
Falany CN, Krasnykh V, Falany JL (1995) Bacterial expression and characterization of a cDNA for human liver estrogen sulfotransferase. J Steroid Biochem Mol Biol 52:529–539
Falany JL, Azziz R, Falany CN (1998) Identification and characterization of cytosolic sulfotransferases in normal human endometrium. Chem Biol Interact 109:329–339
Falany CN, Xie X, Wang J, Ferrer J, Falany JL (2000) Molecular cloning and expression of novel sulphotransferase-like cDNAs from human and rat brain. Biochem J 346:857–864
Forbes-Bamforth KJ, Coughtrie MWH (1994) Identification of a new adult human liver sulfotransferase with specificity for endogenous and xenobiotic estrogens. Biochem Biophys Res Commun 198:707–711
Frame LT, Gatlin TL, Kadlubar FF, Lang NP (1997) Metabolic differences and their impact on human disease: sulfotransferase and colorectal cancer. Environ Toxicol Pharmacol 4:277–281
Freimuth RR, Raftogianis RB, Wood TC, Moon E, Kim U-J, Xu J, Siciliano MJ, Weinshilboum RM (2000) Human sulfotransferases SULT1C1 and SULT1C2: cDNA characterization, gene cloning, and chromosomal localization. Genomics 65:157–165
Freimuth RR, Eckloff B, Wieben ED, Weinshilboum RM (2001) Human sulfotransferase SULT1C1 pharmacogenetics: gene resequencing and functional genomic studies. Pharmacogenetics 11:747–756
Fuda H, Lee YC, Shimizu C, Javitt NB, Strott CA (2002) Mutational analysis of human hydroxysteroid sulfotransferase SULT2B1 isoforms reveals that exon 1B of the SULT2B1 gene produces cholesterol sulfotransferase, whereas exon 1A yields pregnenolone sulfotransferase. J Biol Chem 277:36161–36166
Fujita K, Nagata K, Ozawa S, Sasano H, Yamazoe Y (1997) Molecular cloning and characterization of rat ST1B1 and human ST1B2 cDNAs, encoding thyroid hormone sulfotransferases. J Biochem (Tokyo) 122:1052–1061
Geese WJ, Raftogianis RB (2001) Biochemical characterization and tissue distribution of human SULT2B1. Biochem Biophys Res Commun 288:280–289
Glatt HR (1997) Sulfation and sulfotransferases. 4. Bioactivation of mutagens via sulfation. FASEB J 11:314–321
Glatt HR (2000) Sulfotransferases in the bioactivation of xenobiotics. Chem Biol Interact 129:141–170
Glatt HR (2001) Genetische Polymorphismen von Sulfotransferasen als Suszeptibilitätsparameter. In: Angerer J, Weiss T (eds) Biological monitoring—heutige und künftige Möglichkeiten in der Arbeits- und Umweltmedizin. Symposium Research Reports of the Deutsche Forschungsgemeinschaft. Wiley-VCH, Weinheim, pp 86–97
Glatt HR (2002) Sulphotransferases. In: Ioannides C (ed) Handbook of enzyme systems that metabolise drugs and other xenobiotics. John Wiley, Sussex, pp 353–439
Glatt HR, Boeing H, Engelke CEH, Ma L, Kuhlow A, Pabel U, Pomplun D, Teubner W, Meinl W (2001) Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. Mutat Res 482:27–41
Hagen M, Pabel U, Landsiedel R, Bartsch I, Falany CN, Glatt HR (1998) Expression of human estrogen sulfotransferase in Salmonella typhimurium: differences between hHST and hEST in the enantioselective activation of 1-hydroxyethylpyrene to a mutagen. Chem Biol Interact 109:249–253
Hamdy SI, Hiratsuka M, Narahara K, Endo N, El-Enany M, Moursi N, Ahmed MS, Mizugaki M (2003) Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population. Br J Clin Pharmacol 55:560–569
Her C, Szumlanski C, Aksoy IA, Weinshilboum RM (1996) Human jejunal estrogen sulfotransferase and dehydroepiandrosterone sulfotransferase: immunochemical characterization of individual variation. Drug Metab Dispos 24:1328–1335
Her C, Kaur GP, Athwal RS, Weinshilboum RM (1997) Human sulfotransferase SULT1C1: cDNA cloning, tissue-specific expression, and chromosomal localization. Genomics 41:467–470
Her C, Wood TC, Eichler EE, Mohrenweiser HW, Ramagli LS, Siciliano MJ, Weinshilboum RM (1998) Human hydroxysteroid sulfotransferase SULT2B1: two enzymes encoded by a single chromosome 19 gene. Genomics 53:284–295
Hernandez JS, Powers SP, Weinshilboum RM (1991) Human liver arylamine N-sulfotransferase activity: thermostable phenol sulfotransferase catalyzes the N-sulfation of 2-naphthylamine. Drug Metab Dispos 19:1071–1079
Hobkirk R (1993) Steroid sulfation: current concepts. Trends Endocrinol Metab 4:69–74
Honma W, Kamiyama Y, Yoshinari K, Sasano H, Shimada M, Nagata K, Yamazoe Y (2001) Enzymatic characterization and interspecies difference of phenol sulfotransferases, ST1A forms. Drug Metab Dispos 29:274–281
Hwang SR, Kohn AB, Hook VYH (1995) Molecular cloning of an isoform of phenol sulfotransferase from human brain hippocampus. Biochem Biophys Res Commun 207:701–707
Iida A, Sekine A, Saito S, Kitamura Y, Kitamoto T, Osawa S, Mishima C, Nakamura Y (2001) Catalog of 320 single nucleotide polymorphisms (SNPs) in 20 quinone oxidoreductase and sulfotransferase genes. J Hum Genet 46:225–240
Javitt NB, Lee YC, Shimizu C, Fuda H, Strott CA (2001) Cholesterol and hydroxycholesterol sulfotransferases: identification, distinction from dehydroepiandrosterone sulfotransferase, and differential tissue expression. Endocrinology 142:2978–2984
Jones AL, Roberts RC, Coughtrie MWH (1993) The human phenolsulphotransferase polymorphism is determined by the level of expression of the enzyme protein. Biochem J 296:287–290
Jones AL, Hagen M, Coughtrie MWH, Roberts RC, Glatt HR (1995) Human platelet phenolsulfotransferases: cDNA cloning, stable expression in V79 cells and identification of a novel allelic variant of the phenol-sulfating form. Biochem Biophys Res Commun 208:855–862
Kawabe S, Ikuta T, Ohba M, Chida K, Ueda E, Yamanishi K, Kuroki T (1998) Cholesterol sulfate activates transcription of transglutaminase 1 gene in normal human keratinocytes. J Invest Dermatol 111:1098–1102
Kester MHA, van Dijk CH, Tibboel D, Hood AM, Rose NJM, Meinl W, Pabel U, Glatt HR, Falany CN, Coughtrie MWH, Visser TJ (1999) Sulfation of thyroid hormone by estrogen sulfotransferase. J Clin Endocrinol Metab 84:2577–2580
Klaassen CD, Boles JW (1997) Sulfation and sulfotransferases. 5. The importance of 3’-phosphoadenosine 5’-phosphosulfate (PAPS) in the regulation of sulfation. FASEB J 11:404–418
Kong ANT, Yang LD, Ma MH, Tao D, Bjornsson TD (1992) Molecular cloning of the alcohol/hydroxysteroid form (hSTa) of sulfotransferase from human liver. Biochem Biophys Res Commun 187:448–454
Kotov A, Falany JL, Wang J, Falany CN (1999) Regulation of estrogen activity by sulfation in human Ishikawa endometrial adenocarcinoma cells. J Steroid Biochem Mol Biol 68:137–144
Landsiedel R, Pabel U, Engst W, Ploschke J, Seidel A, Glatt HR (1998) Chiral inversion of 1-hydroxyethylpyrene enantiomers mediated by enantioselective sulfotransferases. Biochem Biophys Res Commun 247:181–185
Lee HS, Ti TY, Koh YK, Prescott LF (1992) Paracetamol elimination in Chinese and Indians in Singapore. Eur J Clin Pharmacol 43:81–84
Leiter EH, Chapman HD, Falany CN (1991) Synergism of obesity genes with hepatic steroid sulfotransferases to mediate diabetes in mice. Diabetes 40:1360–1363
Li X, Clemens DL, Anderson RJ (2000) Sulfation of iodothyronines by human sulfotransferase 1C1 (SULT1C1). Biochem Pharmacol 60:1713–1716
Liu MC, Sakakibara Y, Liu CC (1999) Bacterial expression, purification, and characterization of a novel mouse sulfotransferase that catalyzes the sulfation of eicosanoids. Biochem Biophys Res Commun 254:65–69
Meinl W, Glatt HR (2001) Structure and localization of the human SULT1B1 gene: neighborhood to SULT1E1 and a SULT1D pseudogene. Biochem Biophys Res Commun 288:855–862
Meinl W, Meerman JH, Glatt HR (2002) Differential activation of promutagens by alloenzymes of human sulfotransferase 1A2 expressed in Salmonella typhimurium. Pharmacogenetics 12:677–689
Meloche CA, Falany CN (2001) Expression and characterization of the human 3β-hydroxysteroid sulfotransferases (SULT2B1a and SULT2B1b). J Steroid Biochem Mol Biol 77:261–269
Miller JA, Surh Y-J (1994) Sulfonation in chemical carcinogenesis. In: Kauffman FC (ed) Handbook of Pharmacology, vol 112: conjugation-deconjugation reactions in drug metabolism and toxicity. Springer, Berlin Heidelberg New York, pp 429–458
Moreno V, Glatt HR, Guino E, Fisher E, Meinl W, Navarro M, Osorio A, Boeing H (2003) Polymorphisms in sulfotransferases SULT1A1 and SULT1A2 are not related to colorectal cancer. Cancer Epidemiol Biomarkers Prevent (in press)
Muckel E, Frandsen H, Glatt HR (2002) Heterologous expression of human N-acetyltransferases 1 and 2 and sulfotransferase 1A1 in Salmonella typhimurium for mutagenicity testing of heterocyclic amines. Food Chem Toxicol 40:1063–1068
Mulder GJ, Jakoby WB (1990) Sulfation. In: Mulder GJ (ed) Conjugation reactions in drug metabolism: an integrated approach. Taylor and Francis, London, pp 107–161
Nagata K, Yamazoe Y (2000) Pharmacogenetics of sulfotransferase. Annu Rev Pharmacol Toxicol 40:159–176
Nash RM, Stein L, Penno MB, Passananti GT, Vesell ES (1984) Sources of interindividual variations in acetaminophen and antipyrine metabolism. Clin Pharmacol Ther 36:417–430
Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC, Nebert DW (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6:1–42
Nowell S, Coles B, Sinha R, MacLeod S, Luke Ratnasinghe D, Stotts C, Kadlubar FF, Ambrosone CB, Lang NP (2002a) Analysis of total meat intake and exposure to individual heterocyclic amines in a case-control study of colorectal cancer: contribution of metabolic variation to risk. Mutation Res 506–507:175–185
Nowell S, Sweeney C, Winters M, Stone A, Lang NP, Hutchins LF, Kadlubar FF, Ambrosone CB (2002b) Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy. J Natl Cancer Inst 94:1635–1640
Ozawa S, Nagata K, Shimada M, Ueda M, Tsuzuki T, Yamazoe Y, Kato R (1995) Primary structures and properties of two related forms of aryl sulfotransferases in human liver. Pharmacogenetics 5:S135–S140
Ozawa S, Tang YM, Yamazoe Y, Kato R, Lang NP, Kadlubar FF (1998) Genetic polymorphisms in human liver phenol sulfotransferases involved in the bioactivation of N-hydroxy derivatives of carcinogenic arylamines and heterocyclic amines. Chem Biol Interact 109:237–248
Ozawa S, Shimizu M, Katoh T, Miyajima A, Ohno Y, Matsumoto Y, Fukuoka M, Tang YM, Lang NP, Kadlubar FF (1999) Sulfating-activity and stability of cDNA-expressed allozymes of human phenol sulfotransferase, ST1A3*1 (213Arg) and ST1A3*2 (213His), both of which exist in Japanese as well as Caucasians. J Biochem (Tokyo) 126:271–277
Ozawa S, Katoh T, Inatomi H, Imai H, Kuroda Y, Ichiba M, Ohno Y (2002) Association of genotypes of carcinogen-activating enzymes, phenol sulfotransferase SULT1A1 (ST1A3) and arylamine N-acetyltransferase NAT2, with urothelial cancer in a Japanese population. Int J Cancer 102:418–421
Park-Chung M, Malayev A, Purdy RH, Gibbs TT, Farb DH (1999) Sulfated and unsulfated steroids modulate γ-aminobutyric acid A receptor function through distinct sites. Brain Res 830:72–87
Peng CT, Chen JC, Yeh KT, Wang YF, Hou MF, Lee TP, Shih MC, Chang JY, Chang JG (2003) The relationship among the polymorphisms of SULT1A1, 1A2 and different types of cancers in Taiwanese. Int J Mol Med 11:85–89
Petrotchenko EV, Pedersen LC, Borchers CH, Tomer KB, Negishi M (2001) The dimerization motif of cytosolic sulfotransferases. FEBS Lett 490:39–43
Price RA, Cox NJ, Spielman RS, Van Loon JA, Maidak BL, Weinshilboum RM (1988) Inheritance of human platelet thermolabile phenol sulfotransferase (TL PST) activity. Genet Epidemiol 5:1–15
Price RA, Spielman RS, Lucena AL, Van Loon JA, Maidak BL, Weinshilboum RM (1989) Genetic polymorphism for human platelet thermostable phenol sulfotransferase (TS PST) activity. Genetics 122:905–914
Raftogianis RB, Wood TC, Otterness DM, van Loon JA, Weinshilboum RM (1997) Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. Biochem Biophys Res Commun 239:298–304
Raftogianis RB, Wood TC, Weinshilboum RM (1999) Human phenol sulfotransferases SULT1A2 and SULT1A1: genetic polymorphisms, allozyme properties, and human liver genotype-phenotype correlations. Biochem Pharmacol 58:605–616
Roberts KD (1987) Sterol sulfates in the epididymis; synthesis and possible function in the reproductive process. J Steroid Biochem 27:337–341
Rubin GL, Harrold AJ, Mills JA, Falany CN, Coughtrie MWH (1999) Regulation of sulphotransferase expression in the endometrium during the menstrual cycle, by oral contraceptives and during early pregnancy. Mol Hum Reprod 5:995–1002
Runge-Morris MA (1997) Sulfation and sulfotransferases. 2. Regulation of expression of the rodent cytosolic sulfotransferases. FASEB J 11:109–117
Sachse C, Smith G, Wilkie MJ, Barrett JH, Waxman R, Sullivan F, Forman D, Bishop DT, Wolf CR (2002) A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis 23:1839–1849
Sakakibara Y, Yanagisawa K, Katafuchi J, Ringer DP, Takami Y, Nakayama T, Suiko M, Liu MC (1998a) Molecular cloning, expression, and characterization of novel human SULT1C sulfotransferases that catalyze the sulfonation of N-hydroxy-2-acetylaminofluorene. J Biol Chem 273:33929–33935
Sakakibara Y, Yanagisawa K, Takami Y, Nakayama T, Suiko M, Liu M-C (1998b) Molecular cloning, expression, and functional characterization of novel mouse sulfotransferases. Biochem Biophys Res Commun 247:681–686
Seth P, Lunetta KL, Bell DW, Gray H, Nasser SM, Rhei E, Kaelin CM, Iglehart DJ, Marks JR, Garber JE, Haber DA, Polyak K (2000) Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer. Cancer Res 60:6859–6863
Shiraga T, Hata T, Yamazoe Y, Ohno Y, Iwasaki K (1999a) N-Sulphoconjugation of amines by human cytosolic hydroxysteroid sulphotransferase. Xenobiotica 29:341–347
Shiraga T, Iwasaki K, Hata T, Yoshinari K, Nagata K, Yamazoe Y, Ohno Y (1999b) Purification and characterization of two amine N-sulfotransferases, AST-RB1 (ST3A1) and AST-RB2 (ST2A8), from liver cytosols of male rabbits. Arch Biochem Biophys 362:265–274
Singer SS (1985) Preparation and characterization of the different kinds of sulfotransferases. In: Zakim D, Vessey DA (eds) Methodological aspects of drug metabolizing enzymes. Wiley, New York, pp 95–159
Singer SS, Palmert MR, Redman MD, Leahy DM, Feeser TC, Lucarelli MJ, Volkwein LS, Bruns M (1988) Hepatic dopamine sulfotransferases in untreated rats and in rats subjected to endocrine or hypertension-related treatments. Hepatology 8:1511–1520
Steiner M, Bastian M, Schulz WA, Pulte T, Franke KH, Rohring A, Wolff JM, Seiter H, Schuff-Werner P (2000) Phenol sulphotransferase SULT1A1 polymorphism in prostate cancer: lack of association. Arch Toxicol 74:222–225
Strott CA (1996) Steroid sulfotransferases. Endocrine Rev 17:670–697
Strott CA (2002) Sulfonation and molecular action. Endocr Rev 23:703–732
Suiko M, Sakakibara Y, Liu MC (2000) Sulfation of environmental estrogen-like chemicals by human cytosolic sulfotransferases. Biochem Biophys Res Commun 267:80–84
Tang D, Rundle A, Mooney L, Cho S, Schnabel F, Estabrook A, Kelly A, Levine R, Hibshoosh H, Perera F (2003) Sulfotransferase 1A1 (SULT1A1) polymorphism, PAH-DNA adduct levels in breast tissue and breast cancer risk in a case-control study. Breast Cancer Res Treat 78:217–222
Teubner W, Pabel U, Meinl W, Coughtrie MWH, Falany CN, Kretzschmar M, Seidel A, Glatt HR (1998) Characterisation of sulfotransferases in human colon mucosa and their expression in Salmonella typhimurium for the study of the activation of promutagens. Naunyn-Schmiedebergs Arch Pharmacol 357:R135
Thomae BA, Eckloff BW, Freimuth RR, Wieben ED, Weinshilboum RM (2002) Human sulfotransferase SULT2A1 pharmacogenetics: genotype-to-phenotype studies. Pharmacogenomics J 2:48–56
Tsoi C, Falany CN, Morgenstern R, Swedmark S (2001) Identification of a new subfamily of sulphotransferases: cloning and characterization of canine SULT1D1. Biochem J 356:891–897
Visser TJ (1996) Pathways of thyroid hormone metabolism. Acta Med Austriaca 23:10–16
Walther SE, Dunbrack RL, Raftogianis RB (1999) Cloning, expression and characterization of a human sulfotransferase, SULT4A1, that represents a novel SULT family. ISSX Proc 15:388
Wang J, Falany JL, Falany CN (1998) Expression and characterization of a novel thyroid hormone-sulfating form of cytosolic sulfotransferase from human liver. Mol Pharmacol 53:274–282
Wang Y, Spitz MR, Tsou AM, Zhang K, Makan N, Wu X (2002) Sulfotransferase (SULT) 1A1 polymorphism as a predisposition factor for lung cancer: a case-control analysis. Lung Cancer 35:137–142
Weinshilboum RM, Otterness DM, Aksoy IA, Wood TC, Her C, Raftogianis RB (1997) Sulfotransferase molecular biology. 1. cDNAs and genes. FASEB J 11:3–14
Wong CF, Liyou N, Leggett B, Young J, Johnson A, McManus ME (2002) Association of the SULT1A1 R213H polymorphism with colorectal cancer. Clin Exp Pharmacol Physiol 29:754–758
Wood TC, Her C, Aksoy I, Otterness DM, Weinshilboum RM (1996) Human dehydroepiandrosterone sulfotransferase pharmacogenetics: quantitative western analysis and gene sequence polymorphisms. J Steroid Biochem Mol Biol 59:467–478
Wu MT, Wang YT, Ho CK, Wu DC, Lee YC, Hsu HK, Kao EL, Lee JM (2003) SULT1A1 polymorphism and esophageal cancer in males. Int J Cancer 103:101–104
Yang M, Kim SY, Lee SM, Chang SS, Kawamoto T, Jang JY, Ahn YO (2003) Biological monitoring of bisphenol a in a Korean population. Arch Environ Contam Toxicol 44:546–551
Yoshinari K, Nagata K, Shimada M, Yamazoe Y (1998a) Molecular characterization of ST1C1-related human sulfotransferase. Carcinogenesis 19:951–953
Yoshinari K, Nagata K, Shiraga T, Iwasaki K, Hata T, Ogino M, Ueda R, Fujita K, Shimada M, Yamazoe Y (1998b) Molecular cloning, expression, and enzymatic characterization of rabbit hydroxysteroid sulfotransferase AST-RB2 (ST2A8). J Biochem (Tokyo) 123:740–746
Young WF Jr, Laws ER Jr, Sharbrough FW, Weinshilboum RM (1985) Human phenol sulfotransferase: correlation of brain and platelet activities. J Neurochem 44:1131–1137
Zhang HP, Varmalova O, Vargas FM, Falany CN, Leyh TS (1998) Sulfuryl transfer: the catalytic mechanism of human estrogen sulfotransferase. J Biol Chem 273:10888–10892
Zheng W, Xie DW, Cerhan JR, Sellers TA, Wen WQ, Folsom AR (2001) Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarker Prev 10:89–94
Zhu XY, Veronese ME, Iocco P, McManus ME (1996) cDNA cloning and expression of a new form of human aryl sulfotransferase. Int J Biochem Cell Biol 28:565–571
Zou LB, Yamada K, Sasa M, Nakata Y, Nabeshima T (2000) Effects of σ1 receptor agonist SA4503 and neuroactive steroids on performance in a radial arm maze task in rats. Neuropharmacology 39:1617–1627
Acknowledgements
Our research on SULTs has been financially supported by the Deutsche Forschungsgemeinschaft (INK 26), Bundesministerium für Bildung, Wissenschaft, Forschung und Technologie (grant 0311243) and the European Union (grant QLK1-CT99-01197).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Glatt, H., Meinl, W. Pharmacogenetics of soluble sulfotransferases (SULTs). Naunyn-Schmiedeberg's Arch Pharmacol 369, 55–68 (2004). https://doi.org/10.1007/s00210-003-0826-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-003-0826-0